Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

All Eyes on EFSA's new 'independence policy'

Brussels, Wednesday 14 December 2011- The European Food Safety Authority (EFSA) has today published a new independence policy, aimed at improving EFSA's independence in delivering scientific opinions on food safety [1]. This new policy, developed following a public consultation and stakeholder workshop in October, will be up for approval by the EFSA Management Board when it meets on Thursday 15 December, in Warsaw.

EFSA, which plays a key role in deciding which products and substances are safe to eat, has been under heavy criticism because of apparent conflicts of interest among its staff and experts. Corporate Europe Observatory and other organisations have over documented links between EFSA's management board and some of its expert panels with the agribusiness industry (see table below).

CEO has also criticised EFSA's heavy reliance on industry data and the way in which it systematically excludes independent scientific studies from its assessments.

A draft policy, published by EFSA earlier this year, failed to address many of the conflicts of interest identified, CEO said in response to the consultation.

CEO argues that EFSA has until now failed to recognise the problem posed by conflicts of interest. While the EU institutions are responsible for the membership of EFSA's Management Board, EFSA is responsible for selecting the members of the expert panels, and deciding in which cases there is a conflict of interest.

Nina Holland, campaigner at CEO said:

"Experts who have a vested interest in EFSA decisions because of links to industry should not be allowed to sit on expert panels providing scientific advice. So, for example, someone whose laboratory is funded by Nestlé, should not be allowed on the food additives panel (ANS Panel) as currently is the case, because Nestlé has an active interest in almost all food additives. The new policy must clearly ban conflicts of interest by setting clear criteria for panel members' independence."

CEO will assess ESFA's new independence policy to see whether the radical improvements that are needed have been made.

Last week, the European Ombudsman sided with NGOs, ruling that the EFSA management had failed to act properly in the case of Suzy Renckens, who moved straight through the revolving door into a lobby job with Syngenta after serving on the EFSA GMO Panel.

The European Parliament Environment Committee will discuss EFSA's independence from industry next week, when deciding on the approval of EFSA's 2010 budget (20 December).

For more information please contact:
Nina Holland, Corporate Europe Observatory, nina@corporateeurope.org

Notes:
[1] The Draft Policy on Independence and Scientific Decision-Making Processes incorporating changes resulting from the Public Consultation process will be discussed at the Management Board meeting in Warsaw on Thursday 15 December 2011. The text is available on EFSA website at http://www.efsa.europa.eu/en/mb111215/docs/mb111215-ax8a.pdf

EFSA’s technical report on the outcome of the public consultation on the draft Policy on Independence and Scientific Decision-Making Processes is online at: http://www.efsa.europa.eu/en/supporting/pub/indipendence.htm

Table: Overview of Conflicts of Interest at EFSA (CEO 2011)

Related issues: 
 

More than 80 per cent of the national experts involved in the EU's official assessment of glyphosate refused to have their names disclosed to the public.

Monsanto and the pesticide industry breathed a collective sigh of relief on 12 November 2015. The findings of an investigation into the toxicity of glyphosate by the European Food Safety Authority (EFSA) and EU Member States were in stark contradiction to the March 2015 conclusion by the International Agency for Research against Cancer (IARC), a body of the World Health Organization (WHO), that this agricultural herbicide was probably causing cancer to humans. If validated, this conclusion could cause a partial ban of glyphosate in the EU. [UPDATED on 30 11 2015 16.30 CET]

Open letter to Commissioner Andriukaitis on glyphosate

Heard by the European Parliament's Committee on the Environment, Public Health and Food Safety, Bernhard Url, EFSA's director, said that the EU had "enough scientific capability around [...] without a chief scientific adviser".

Commission refuses to act on the recommendations of the European Ombudsman regarding tobacco industry lobbying.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate